| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |